LPL Financial’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
PC
PCM
PHS
TFCM
CCM
LPL Financial's CLPT Position: Q2 2026 in Review
LPL Financial increased its ClearPoint Neuro (CLPT) stake by 6.5% in Q2 2026, buying an estimated $52.5K and bringing the position to 68,391 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #4248.
LPL Financial first reported a position in CLPT in Q2 2021 and has held it in 21 quarters since. 45 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.
- LPL Financial held 68,391 shares of ClearPoint Neuro worth $1.22M as of Q2 2026.
- LPL Financial bought 4,200 ClearPoint Neuro shares in Q2 2026, an estimated $52.5K.
- ClearPoint Neuro made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4248 holding.
- LPL Financial first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 21 quarters since.
- 45 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.